Monitoring of Women with Anti-Ro/SSA and Anti-La/SSB Antibodies in Germany—Status Quo and Intensified Monitoring Concepts
<b>Background:</b> The fetuses of pregnant women affected by anti-Ro/anti-La antibodies are at risk of developing complete atrioventricular heart block (CAVB) and other potentially life-threatening cardiac affections. CAVB can develop in less than 24 h. Treatment with anti-inflammatory d...
Main Authors: | Ivonne Alexandra Bedei, David Kniess, Corinna Keil, Aline Wolter, Johanna Schenk, Ulrich J. Sachs, Roland Axt-Fliedner |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2024-02-01
|
Series: | Journal of Clinical Medicine |
Subjects: | |
Online Access: | https://www.mdpi.com/2077-0383/13/4/1142 |
Similar Items
-
Possible role of anti-SSA/Ro antibodies in the pathogenesis of pulmonary hypertension
by: Kelsey Guerreso, et al.
Published: (2016-01-01) -
Maternal and infant outcomes of pregnancy associated with anti-SSA/RO antibodies: a systematic review and meta-analysis
by: Xiangrui Sheng, et al.
Published: (2023-03-01) -
Sicca syndrome in the same family – the importance of anti-Ro60, anti-Ro52 and anti-La antibody profiling in Sjögren’s syndrome
by: Arkadiusz Koszarny, et al.
Published: (2021-08-01) -
Spontaneous Remission of Congenital Complete Atrioventricular Block in Anti-Ro/La Antibody-Negative Monozygotic Twins: Case Report
by: Taner Kasar, et al.
Published: (2017-02-01) -
Isolated anti-Ro52 identifies a severe subset of Sjögren’s syndrome patients
by: Adrian Y. S. Lee, et al.
Published: (2023-03-01)